Drug Trial Radar · NCT03840993
Safety and Efficacy Study of MT-2990 in Women With Endometriosis
Last checked: Nov 20, 2026Latest source record: Dec 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
76
Actual
Start
Jan 15, 2019
Primary completion
May 13, 2021
Study completion Oct 5, 2021
Sponsor
- Lead sponsor
- Tanabe Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 15, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 49 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and efficacy of MT-2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis.
Conditions
- Endometrial Related Pain
Interventions
MT-2990Drug
over 16 weeks
PlaceboDrug
over 16 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline to Week 16 in Nonmenstrual Pelvic Pain Using a Pain Scale Ranges From 0 (None) to 3 (Severe)Time frame: Baseline to Week 16
Locations
51 sites in 1 country. Site status is shown where the registry gives one.
Precision Trials
Phoenix, Arizona
Northern California Research Corporation
Sacramento, California
Ageless and Beautiful Medical Spa
San Diego, California
Precision Research Institute
San Diego, California
The Lundquist Institute at Harbor-UCLA Medical Center
Torrance, California
Clinical Physiology Associates - Fort Myers
Fort Myers, Florida
AGA Clinical Trials
Hialeah, Florida
Kendall South Medical Center
Hialeah, Florida
South Florida Clinical Trials
Hialeah, Florida
Altus Research
Lake Worth, Florida
Axcess Medical Research
Loxahatchee Groves, Florida
Health and Life Research Institute
Miami, Florida
Ivetmar Medical Group
Miami, Florida
Future Care Solution
Miami, Florida
Advanced Medical Research Institute
Miami, Florida
South Florida Research Phase I-IV
Miami Springs, Florida
American Research Centers of Florida
Pembroke Pines, Florida
Agile Clinical Research Trials
Alpharetta, Georgia
Medi-Sense
Atlanta, Georgia
NuDirections Clinical Research
Dunwoody, Georgia
Drug Studies America - Marietta
Marietta, Georgia
Clinical Research Prime
Idaho Falls, Idaho
Rosemark Women Care Specialists
Idaho Falls, Idaho
Advanced Clinical Research - Idaho
Meridian, Idaho
The Advanced Gynecologic Surgery Institute
Park Ridge, Illinois
GTC Research
Shawnee Mission, Kansas
Clinical Trials Management - Covington Northshore Office
Covington, Louisiana
Southern Clinical Research Associates
Metairie, Louisiana
Omni Fertility and Laser Institute
Shreveport, Louisiana
Continental Clinical Solutions
Towson, Maryland
Saginaw Valley Medical Research Group/Women's OB-GYN
Saginaw, Michigan
Albuquerque Clinical Trials
Albuquerque, New Mexico
Manhattan Medical Research
New York, New York
Carolina Women's Research and Wellness Clinic
Durham, North Carolina
Unified Women's Clinical Research - Raleigh
Raleigh, North Carolina
PMG Research of Rocky Mount
Rocky Mount, North Carolina
Lyndhurst Gynecologic Associates
Winston-Salem, North Carolina
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Aventive Research - Colombus
Columbus, Ohio
North Star Medical Research
Middleburg Heights, Ohio
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.